Musk insists Tesla does not need more capital, predicts profit soon
(Reuters) – Tesla Inc (TSLA.O) will be profitable in the third and fourth quarters of this year and will not have to raise any money from investors, billionaire Chief Executive…
Theranos lays off most of its remaining workforce: WSJ
(Reuters) – Embattled blood-testing company Theranos Inc laid off most of its remaining workforce to preserve cash and avert or at least delay bankruptcy for a few more months, the…
T-Mobile restarts talks to acquire Sprint: source
(Reuters) – T-Mobile US Inc (TMUS.O) is engaged in a new round of talks to acquire Sprint Corp (S.N), a person familiar with the matter said on Tuesday, the latest…
Merck’s Keytruda helps lung cancer patients live longer in trial
(Reuters) – Merck & Co’s (MRK.N) blockbuster drug Keytruda helped previously untreated lung cancer patients live longer in a late-stage trial, potentially cementing its position as the dominant player in…
New Jersey health officials investigating potential E.coli outbreak
(Reuters) – Health officials in New Jersey said they are investigating an E. coli outbreak in four counties that left at least eight people hospitalized. FILE PHOTO: Colonies of E.…
Campbell Soup gives COO Mignini more control over core units
(Reuters) – Campbell Soup Co (CPB.N) said on Thursday it would reorganize its businesses, giving newly-appointed Chief Operating Officer Luca Mignini more control over its main units, including soup, simple…
Facebook shares rise as Zuckerberg soothes investors
(Reuters) – Shares of Facebook Inc rose as much as 4.2 percent on Thursday after Chief Executive Officer Mark Zuckerberg said the social network had not seen any meaningful impact…
Lilly’s Cyramza succeeds in late-stage liver cancer trial
(Reuters) – Eli Lilly and Co on Wednesday said its drug Cyramza met the main goal of helping patients live longer in a late-stage trial, which tested it as a…
Pfizer signs deal with Allogene to develop cancer cell therapy
(Reuters) – Pfizer Inc said on Tuesday it signed an agreement with Allogene Therapeutics, a company formed by a consortium in which the drugmaker will hold a 25 percent stake,…
FDA refuses to review Alkermes’ depression treatment, seeks more trials
(Reuters) – Alkermes Plc has been told to conduct more clinical trials of its experimental depression treatment after the U.S. Food and Drug Administration rejected its initial application for approval,…